Global Transplant Diagnostics Devices Market was valued at US$ 3.25 Bn in 2017, and is expected to reach US$ 7.8 by 2026, at a CAGR of 11.56 during forecast period.
Transplant diagnostics is the most important histocompatibility in humans, which is quite consistent with chromosome six-based genes. Human leukocyte antigen (HLA) diagnostic testing is done to determine tissue consistency between the oxy and bone marrow transplant contributor and recipients.
A few key factors boosting the overall growth of transplant diagnostics include increase in number of transplantation procedures and the rise in number of patients suffering from chronic diseases frequently leading to organ failure. In addition to this, it is the industrial advancements in the field of transplant diagnostics, growth in finance for the research activities, and rise in impediment of infectious diseases are some other important factors responsible for the upsurge in the Global Transplant Diagnostics Devices Market.
Global Transplant Diagnostics Devices Market is segmented by technology, product and services, transplant type, application, end user, and region. The global transplant diagnostics devices have the largest usage in independent reference laboratories, hospitals, transplant centre, and research laboratories & academic institutes.
As the different regions are taken into consideration, North America among all others held the highest Global Transplant Diagnostics Devices Market share in 2016 followed by Europe, and is estimated to grow at the highest growth rate during the forecast period. The auxiliary regime initiatives and considerable enforcement of practice guidelines relinquished by healthcare organizations present across this region are some of the key factors responsible for the high share registered by the North America region. Furthermore, high adoption of amended medicines, stem cell therapies, and soft tissue transplants are also enhancing the regional market magnification of the Global Transplant Diagnostics Devices Market.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Transplant Diagnostics Devices market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in Transplant Diagnostics Devices market
For More Information Visit
The years that have been considered for the study are:
• Base year – 2017
• Estimated year – 2018
• Forecast period – 2017 to 2026
Scope of Global Transplant Diagnostics Devices Market:
Global Transplant Diagnostics Devices Market By Technology:
• Molecular Assay Technologies
• PCR-Based Molecular Assay Technologies
o Real-Time PCR
o Sequence-Specific Primer-PCR (SSP-PCR)
o Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
o Other PCR Technologies
• Sequencing-Based Molecular Assay Technologies
o Sanger Sequencing
o Next-Generation Sequencing (NGS)
o Other Sequencing Technologies
• Non-Molecular Assay Technologies
Global Transplant Diagnostics Devices Market by Products & Service:
• Reagents & Consumables
• Instruments
• Software & Services
Global Transplant Diagnostics Devices Market by Transplant Type:
• Solid Organ Transplantation
o Kidney
o Liver
o Lung
o Heart
o Pancreas
o Other Organs
• Stem Cell Transplantation
• Soft Tissue Transplantation
Global Transplant Diagnostics Devices Market by Application:
• Diagnostic Application
• Pre-Transplantation
o Infectious Diseases Testing
o Histocompatibility Testing
o Blood Profiling
• Post-Transplantation
• Research Application
Global Transplant Diagnostics Devices Market by End Users:
• Independent Reference Laboratories
• Hospitals & Transplant Centres
• Research Laboratories & Academic Institutes
Global Transplant Diagnostics Devices Market by Region:
North America
• U.S
• Canada
Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Rest of Asia Pacific
Rest of the World (ROW):
• Middle-East
• Africa
• Latin America
Key Players Operated in Global Transplant Diagnostics Devices market Include:
• Abbott Laboratories Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Immucor, Inc.
• Linkage Biosciences
• Olerup Ssp Ab
• Qiagen N.V.
• bioMérieux
• Becton
• Dickinson and Company
• Merck KGAA
• Hologic
• Luminex
• Thermo Fisher Scientific Inc
• Sigma-Aldrich among others.
Research Methodology:
The market is estimated by analysing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of market were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this analysis. This country specific analysis was accumulated to establish regional numbers and then arrive at global market value for global transplant diagnostics Market.
This Report Is Submitted By @Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.
Global Transplant Diagnostics Devices Market was valued at USD3.25 billion in 2017, and is estimated to grow at a CAGR of 7.5% from 2017 to 2024.
Transplant diagnostics is the most important histocompatibility in humans, which is quite consistent with chromosome six-based genes.
In addition to this, it is the industrial advancements in the field of transplant diagnostics, growth in finance for the research activities, and rise in impediment of infectious diseases are some other important factors responsible for the upsurge in the Global Transplant Diagnostics Devices Market.For More Information Visit https://www.maximizemarketresearch.com/market-report/global-transplant-diagnostics-devices-market/10869/Global Transplant Diagnostics Devices Market is segmented by technology, product and services, transplant type, application, end user, and region.
As the different regions are taken into consideration, North America among all others held the highest Global Transplant Diagnostics Devices Market share in 2016 followed by Europe, and is estimated to grow at the highest growth rate during the forecast period.
Furthermore, high adoption of amended medicines, stem cell therapies, and soft tissue transplants are also enhancing the regional market magnification of the Global Transplant Diagnostics Devices Market.
The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024This Report Is Submitted By @Maximize Market Research CompanyCustomization of the report:Maximize Market Research provides free personalized of reports as per your demand.
Global Transplant Diagnostics Market Information, Product & Service (Instruments, Reagents & Consumables), Screening Type (Pre-Transplant, Post-Transplant), Organ Type (Kidney, Liver, Heart, Lung, Pancreas), Application Type, End-User – Forecast to 2023Global Transplant Diagnostics Market - Overview Antibody-mediated refusal of organ allografts is difficult to treat as barriers following allotransplantation.
Enhanced diagnostics has permitted better detection and specificity-determination of antibodies precise for a donor Human Leukocyte Antigens (HLA).
One of the possible solutions to this problem is the use of tissues/organs/ cells from animals for transplantation to man, which is also known as xenotransplantation.
The outstanding survival and success rates of transplantation of organs and cells, such as the kidney, liver and heart or haematopoietic stem cells in immunosuppressed patients, have led to extraordinary levels of demand globally.
It is, nevertheless, clear that ethically-unacceptable practices occur in a number of countries globally.
The alternate treatments and medical support for patients with end stage organ failure, particularly renal dialysis, are expensive and narrowed down in various countries globally.
